OncoMed Pharmaceuticals, Inc. Debt to Equity Ratio 2013-2018 | OMED
Current and historical debt to equity ratio values for OncoMed Pharmaceuticals, Inc. (OMED) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. OncoMed Pharmaceuticals, Inc. debt/equity for the three months ending December 31, 2018 was .
Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2018-12-31 |
$0.02B |
$0.05B |
0.35 |
2018-09-30 |
$0.03B |
$0.05B |
0.49 |
2018-06-30 |
$0.04B |
$0.04B |
0.95 |
2018-03-31 |
$0.05B |
$0.05B |
1.05 |
2017-12-31 |
$0.16B |
$-0.05B |
-3.27 |
2017-09-30 |
$0.18B |
$-0.06B |
-2.94 |
2017-06-30 |
$0.19B |
$-0.05B |
-3.59 |
2017-03-31 |
$0.21B |
$-0.04B |
-5.10 |
2016-12-31 |
$0.22B |
$-0.02B |
-9.49 |
2016-09-30 |
$0.22B |
$-0.00B |
-69.59 |
2016-06-30 |
$0.23B |
$-0.04B |
-5.18 |
2016-03-31 |
$0.23B |
$-0.02B |
-11.34 |
2015-12-31 |
$0.23B |
$0.00B |
65.99 |
2015-09-30 |
$0.16B |
$0.03B |
6.42 |
2015-06-30 |
$0.16B |
$0.05B |
3.52 |
2015-03-31 |
$0.16B |
$0.07B |
2.51 |
2014-12-31 |
$0.17B |
$0.08B |
2.25 |
2014-09-30 |
$0.18B |
$0.09B |
2.01 |
2014-06-30 |
$0.19B |
$0.09B |
2.08 |
2014-03-31 |
$0.20B |
$0.11B |
1.85 |
2013-12-31 |
$0.22B |
$0.12B |
1.83 |
2013-09-30 |
$0.04B |
$0.10B |
0.44 |
2013-06-30 |
$0.05B |
$0.02B |
2.18 |
2013-03-31 |
$0.00B |
|
0.00 |
2012-09-30 |
$0.00B |
|
0.00 |
2012-06-30 |
$0.00B |
|
0.00 |